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Improving Outcome Prediction Accuracy of Carotid Endarterectomy
(CEA) in Asymptomatic Patients Using a Novel Frailty Risk Score
(FRS)>
Anton N. Sidawy, Richard F. Neville, Bao N. Nguyen, Gurusher Panjrath,
Richard Amdur. George Washington University, Wash, D.C.
Objectives: CEA in asymptomatic patients is recommended only
when postoperative complications and mortality are kept low; but predicting
CEA complications in a speciﬁc patient remains elusive. To better predict
30-day postoperative outcomes, we calculated a novel point-weight ordinal
Frailty Risk Score (FRS) by an analysis of 20 preoperative risk factors based
on their individual odds ratios (ORs) as predictors of postoperative compli-
cations using all vascular surgery cases in the 2005 to 2011 American
College of Surgeons National Surgical Quality Improvement Program
(ACS-NSQIP) database (n ¼ 121,015).
Methods: To compare the predictive value of this calculated FRS with
that of patient demographics and surgical variables alone, we examined the
predictive contribution value of ﬁve levels of FRS on four outcomes (stroke,
myocardial infarction [MI], and mortality), and a composite of the three
outcomes in all primary asymptomatic CEAs in the 2005 to 2011 ACS-
NSQIP database (n ¼ 39,859).
Results: Thirty-day mortality occurred in 273 patients (0.7%), stroke
in 527 (1.3%), MI in 301 (0.8%), and the composite outcome was positive
in 1008 (2.5%). We found that by itself, the FRS level was strongly and
signiﬁcantly associated with all four outcomes (Table). For stroke, we
used only three levels of frailty because the stroke rate no longer increased
after this point, and found that for the lowest vs highest frailty levels, the
rate of stroke was 1.1% vs 2.4% (P < .0001). Percentage of patients that
were positive for the composite outcome was 1.7% in lowest vs 15.2% in
the highest FRS group (P < .0001).
Conclusions: An easy-to-calculate FRS can help stratify risk based on
preoperative patient characteristics and will help to identify asymptomatic
patients for whom CEA is risky.Table. Percentage of patients positive for each outcome by frailty level
Frailty
level
Death, Stroke, MI, Composite outcome,
% (95% CI) % (95% CI) % (95% CI) % (95% CI)
1 0.2 (0.2-0.3) 0.2 (0.2-0.3) 0.4 (0.3-0.5) 1.7 (1.5-1.9)
2 0.7 (0.6-0.9) 1.3 (1.2-1.5) 0.8 (0.7-0.9) 2.6 (2.4-2.8)
3 1.6 (1.2-2.0) 2.4 (1.9-2.9) 1.7 (1.3-2.1) 5.1 (4.4-5.8)
4 3.0 (1.7-4.4) 1.6 (0.6-2.6) 2.2 (1.1-3.4) 6.4 (4.5. 8.3)
5 10.7 (5.0-16.4) 1.8 (0-4.2) 5.4 (1.2-9.5) 15.2 (8.5-21.8)
CI, Conﬁdence interval; MI, myocardial infarction.Disclosures: A. N. Sidawy: Nothing to disclose; R. F. Neville: Nothing to
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Development of a Successful Follow-Up Program for Patients After
Endovascular Aneurysm Repairy
Larson Erb,1 Julie Adams,1 Daniel Bertges,1 Michael Ricci,2 Georg
Steinthorsson,1 Andrew Stanley,1 Beth Nutter-Gamache,1 Margaret
Lesage,1 Emily Griffes1. 1University of Vermont, Burlington, Vt; 2Central
Maine Health Center, Lewiston, Me
Objectives: Patients treated with endovascular abdominal aortic aneu-
rysm (AAA) repair (EVAR) require lifelong follow-up. Although a variety of
post-EVAR surveillance protocols have been suggested, adherence to
follow-up outside of industry-funded clinical trials has been challenging.
We aim to describe an effective system for EVAR surveillance over 10 years
that results in exceptional follow-up.
Methods: From 2003 to 2013, 225 EVARs were performed for elec-
tive, symptomatic, or ruptured AAA using a variety of commercially avail-
able devices at a single, rural, academic center. After repair, all patients>Eastern Vascular Society
yNew England Society for Vascular Surgerywere followed up every 6 to 12 months with clinic visits and imaging
(computed tomography or ultrasound). All patients were entered into the
Vascular Quality Initiative database, which was audited quarterly by hospital
quality personnel. At the time of the audit, a list of EVAR patients due for
imaging was generated and forwarded to a dedicated vascular clinic nurse
who arranged imaging and clinic visits for those missing follow-up. Mortal-
ity and rationale for incomplete follow-up were recorded in a prospective
follow-up database.
Results: In hospital mortality was 0.9% for elective or symptomatic
AAA and 25% for ruptured AAA. Most (99%) were discharged to home
and 98% remained independent at 1 year. All-cause mortality was 7.2%,
25.4%, 44.9%, and 68.1% at 1, 3, 5, and 10 years. Median follow-up was
3.7 years. Using the above protocol resulted in comprehensive follow-up of
patients at 1, 3, and 5 years of 96%, 92%, and 84%, respectively. A signiﬁcant
drop off in adherence to follow-up was noted at 9 years. Resources required
to accomplish this were minimal, with <0.05 nursing full-time equivalents
and <0.05 full-time equivalents for hospital quality personnel (Fig).
Conclusions: EVAR has acknowledged rates of short-term and long-
term failure so that implantation of the stent graft is only part of successful
treatment of AAA. The follow-up program we describe is comparable to
that achieved in industry-sponsored trials. With many groups currently
participating in the Vascular Quality Initiative, the methodology presented
here is reproducible.
Fig. Follow-up of endovascular abdominal aortic aneurysm (AAA) repair
(EVAR) patients.
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Venous Thromboembolism in High-Risk Patients: Are We Doing
Enough for Prevention?>
Adam C. Ring, Faisal Aziz, Michael J. Beck, Amy B. Reed. Penn State
Hershey College of Medicine, Hershey, Pa
Objectives: Hospital-acquired venous thromboembolism (VTE) is a
costly quality and safety indicator thought to be preventable. Embedding
risk-assessment models into the electronic medical record (EMR) to in-
crease appropriate use of VTE prophylaxis for low-risk, medium-risk, and
high-risk patients is one strategy to decrease VTE events. We proposed
that high-risk patients receiving prophylaxis with mechanical and pharmaco-
logic methods would have a lower VTE rate than those who received one
prophylactic modality or none.
Methods: All medical and surgical patients admitted from October 1,
2011, to October 31, 2012 were reviewed. The EMR was reviewed for the
VTE risk-assessment score determined upon admission, the type of VTE
prophylaxis used, and the rate of hospital-acquired VTE by risk category.
Results: Of the 24,960 patients admitted, 175 (0.71%) developed
VTE during their hospital stay. At the time of admission, 16.7% (4164)
were assigned to the high-risk group, of which 71.3% (2967) received me-
chanical and pharmacologic prophylaxis, 13.0% (542) mechanical alone,>Eastern Vascular Society
